A multicentre study on grey matter morphometric biomarkers for classifying early schizophrenia and parkinson’s disease psychosis

Abstract Psychotic symptoms occur in a majority of schizophrenia patients and in ~50% of all Parkinson’s disease (PD) patients. Altered grey matter (GM) structure within several brain areas and networks may contribute to their pathogenesis. Little is known, however, about transdiagnostic similaritie...

Full description

Bibliographic Details
Main Authors: Franziska Knolle, Shyam S. Arumugham, Roger A. Barker, Michael W. L. Chee, Azucena Justicia, Nitish Kamble, Jimmy Lee, Siwei Liu, Abhishek Lenka, Simon J. G. Lewis, Graham K. Murray, Pramod Kumar Pal, Jitender Saini, Jennifer Szeto, Ravi Yadav, Juan H. Zhou, Kathrin Koch
Format: Article
Language:English
Published: Nature Portfolio 2023-06-01
Series:npj Parkinson's Disease
Online Access:https://doi.org/10.1038/s41531-023-00522-z